Pacira biosciences reports inducement grants under nasdaq listing rule 5635(c)(4)

Brisbane, calif., april 11, 2025 (globe newswire) -- pacira biosciences, inc. (nasdaq: pcrx), the industry leader in the delivery of innovative, non-opioid pain therapies, today announced the granting of inducement awards on april 2, 2025 to 18 new employees under pacira's amended and restated 2014 inducement plan (the “inducement plan”) as a material inducement to each employee's entry into employment with the company. in accordance with nasdaq listing rule 5635(c)(4), the awards were approved by the people & compensation committee of the board of directors (the “committee”) without stockholder approval.
NDAQ Ratings Summary
NDAQ Quant Ranking